APPLICATION
ANDA077440
TYPE
ANDA
ORIGINAL APPROVAL
2006-06-08
LATEST ACTION
2024-05-30
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
POTASSIUM CITRATEPrescription
POTASSIUM CITRATE 10MEQ · TABLET, EXTENDED RELEASE · ORAL
POTASSIUM CITRATEPrescription
POTASSIUM CITRATE 5MEQ · TABLET, EXTENDED RELEASE · ORAL
Approval history
2024-05-30Manufacturing (CMC) · Supplement 5 · unknownAP
2006-06-08OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.